Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice

EMBO Journal

Volumn 15, Issue 12, 1996, Pages 3117-3126

  Wilson, J B ^a   Bell, J L ^a   Levine, A J ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

B cell; EBNA 1; Epstein Barr virus; Lymphoma; Transgenic mice

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0030014205     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00674.x     Document Type: Article

References (41)

1. Adams,J.M., Harris,A.W., Pinkert,C.A., Corcoran,L.M., Alexander,W.S., Cory,S., Palmiter,R.D. and Brinster,R.L. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature, 318, 533-538.
2. Ambinder,R.F., Shah,W.A., Rawlins,D.R., Hayward,G.S. and Hayward, S.D. (1990) Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol., 64, 2369-2379.
3. Ambinder,R.F., Mullen,M., Chang,Y.N., Hayward,G.S. and Hayward, S.D. (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol., 65, 1466-1478.
4. Chen,F., Zou,J.-Z., Di Renzo,L., Winberg,G., Hu,L.-F., Klein,E. and Klein,G. (1995) A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol., 69, 3752-3758.
5. Chen,M.R., Zong,J. and Hayward,S.D. (1994) Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein. Virology, 205, 486-495.
6. Chittenden,T., Lupton,S. and Levine,A.J. (1989) Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication. J. Virol., 63, 3016-3025.
7. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
8. Cohen,J.I., Wang,F., Mannick,J. and Kieff,E. (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA, 86, 9558-9562.
9. Gahn,T.A. and Schildkraut,C.L. (1989) The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell, 58, 527-535.
10. Gahn,T.A. and Sugden,B. (1995) An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol., 69, 2633-2636.
11. Gregory,C.D., Tursz,T., Edwards,C.F., Tetaud,C., Talbot,M., Caillou,B., Rickinson,A.B. and Lipinski,M. (1987) Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J. Immunol., 139, 313-318.
12. Hammerschmidt,W. and Sugden,B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature, 340, 393-397.
13. Hearing,J.C., Lewis,A. and Levine,A.J. (1985) Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodies. Virology, 142, 215-220.
14. Jones,C.H., Hayward,S.D. and Rawlins,D.R. (1989) Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites. J. Virol., 63, 101-110.
15. Kaye,K.M., Izumi,K.M. and Kieff,E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154.
16. Kuhn-Hallek,I., Sage,D.R., Stein,L., Groelle,H. and Fingeroth,J.D. (1995) Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood, 85, 1289-1299.
17. Lupton,S. and Levine,A.J. (1985) Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol., 5, 2533-2542.
18. Mannick,J.B., Cohen,J.L., Birkenbach,M., Marchini,A. and Kieff,E. (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol., 65, 6826-6837.
19. McDonnell,T.J., Deane,N., Platt,F.M., Nunez,G., Jaeger,U., McKearn,J.P. and Korsmeyer,S.J. (1989) bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
20. Nonkwelo,C., Henson,E.B.D. and Sample,J. (1995) Characterization of the Epstein-Barr virus Fp promoter. Virology, 206, 183-195.
21. Qu,L. and Rowe,D.T. (1992) Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol., 66, 3715-3724.
22. Rabbitts,T.H. and Rabbitts,P.H. (1989) Molecular pathology of chromosomal abnormalities and cancer genes in human tumours. In Glover,D.M. and Hanes,B.D. (eds), Oncogenes. IRL Press, Oxford, UK, pp. 67-111.
23. Rawlins,D.R., Milman,G., Hayward,S.D. and Hayward,G.S. (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell, 42, 859-868.
24. Reisman,D. and Sugden,B. (1986) Transactivation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol., 6, 3838-3846.
25. Reisman,D., Yates,J. and Sugden,B. (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol., 5, 1822-1832.
26. Rosenbaum,H., Harris,A.W., Bath,M.L., McNeal,J., Webb,E., Adams, J.M. and Cory,S. (1990) An Eμ-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J., 9, 897-905.
27. Rowe,M., Rowe,D.T., Gregory,C.D., Young,L.S., Farrell,P.J., Rupani,H. and Rickinson,A.B. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitfs lymphoma cells. EMBO J., 6, 2743-2751.
28. Sample,J., Brooks,L., Sample,C., Young,L., Rowe,M., Gregory,C., Rickinson,A. and Kieff,E. (1991) Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl Acad. Sci. USA, 88, 6343-6347.
29. Sample,J., Henson,E.B.D. and Sample,C. (1992) The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J. Virol., 66, 4654-4661.
30. Schaefer,B.C., Woisetschlaeger,M., Strominger,J.L. and Speck,S.H. (1991) Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl Acad. Sci. USA, 88, 6550-6561.
31. Smith,P.R. and Griffin,B.E. (1992) Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J. Virol., 66, 706-714.
32. Snudden,D.K., Hearing,J., Smith,P.R., Grässer,F.A. and Griffin,B.E. (1994) EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J., 13, 4840-4847.
33. Suda,Y., Aizawa,S., Hirai,S.-i., Inoue,T., Furuta,Y., Suzuki,M., Hirohashi,S. and Ikawa,Y. (1987) Driven by the same Ig enhancer and SV40 T promoter, ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBO J., 6, 4055-4065.
34. Sugden,B. and Warren,N. (1989) A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol., 63, 2644-2649.
35. Tomkinson,B., Robertson,E. and Kieff,E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67, 2014-2025.
36. van Lohuizen,M., Verbeek,S., Krimpenfort,P., Domen,J., Saris,C., Radaszkiewicz,T. and Berns,A. (1989) Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56, 673-682.
37. Wilson,J.B. and Levine,A.J. (1992) The oncogenic potential of Epstein-Barr virus nuclear antigen I in transgenic mice. Curr. Topics Microbiol. Immunol., 182, 375-384.
38. Wilson,J.B., Weinberg,W., Johnson,R., Yuspa,S. and Levine,A.J. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell, 61, 1315-1327.
39. Wysokenski,D.A. and Yates,J.L. (1989) Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol., 63, 2657-2666.
40. Yates,J.L., Warren,N., Reisman,D. and Sugden,B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl Acad. Sci. USA, 81, 3806-3810.
41. Yates,J.L., Warren,N. and Sugden,B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature, 313, 812-815.